ADAM10 sheddase activation is controlled by cell membrane asymmetry.


Journal

Journal of molecular cell biology
ISSN: 1759-4685
Titre abrégé: J Mol Cell Biol
Pays: United States
ID NLM: 101503669

Informations de publication

Date de publication:
23 12 2019
Historique:
received: 08 06 2018
revised: 20 11 2018
accepted: 06 02 2019
pubmed: 13 2 2019
medline: 17 7 2020
entrez: 13 2 2019
Statut: ppublish

Résumé

Dysregulation of the disintegrin-metalloproteinase ADAM10 may contribute to the development of diseases including tumorigenesis and Alzheimer's disease. The mechanisms underlying ADAM10 sheddase activation are incompletely understood. Here, we show that transient exposure of the negatively charged phospholipid phosphatidylserine (PS) is necessarily required. The soluble PS headgroup was found to act as competitive inhibitor of substrate cleavage. Overexpression of the Ca2+-dependent phospholipid scramblase Anoctamin-6 (ANO6) led to increased PS externalization and substrate release. Transfection with a constitutively active form of ANO6 resulted in maximum sheddase activity in the absence of any stimulus. Calcium-dependent ADAM10 activation could not be induced in lymphocytes of patients with Scott syndrome harbouring a missense mutation in ANO6. A putative PS-binding motif was identified in the conserved stalk region. Replacement of this motif resulted in strong reduction of sheddase activity. In conjunction with the recently described 3D structure of the ADAM10 extracellular domain, a model is advanced to explain how surface-exposed PS triggers ADAM10 sheddase function.

Identifiants

pubmed: 30753537
pii: 5316298
doi: 10.1093/jmcb/mjz008
pmc: PMC6927242
doi:

Substances chimiques

Anoctamins 0
Biomarkers 0
Membrane Proteins 0
Phosphoserine 17885-08-4
ADAM10 Protein EC 3.4.24.81

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

979-993

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS.

Références

Mol Biol Cell. 2009 Mar;20(6):1785-94
pubmed: 19158376
Biochim Biophys Acta. 2012 Apr;1818(4):1019-27
pubmed: 21920348
Nat Commun. 2016 May 10;7:11523
pubmed: 27161080
J Biol Chem. 2007 May 18;282(20):14836-44
pubmed: 17389606
Semin Cell Dev Biol. 2009 Apr;20(2):126-37
pubmed: 19049889
Circ Res. 2008 May 23;102(10):1192-201
pubmed: 18420943
J Cell Biol. 1988 Mar;106(3):761-71
pubmed: 2450098
Cell Mol Life Sci. 2016 Nov;73(22):4159-4173
pubmed: 27180276
J Biol Chem. 2011 Jul 29;286(30):26931-42
pubmed: 21642425
Nat Immunol. 2006 Dec;7(12):1293-8
pubmed: 17072319
J Biol Chem. 2015 Mar 20;290(12):7416-25
pubmed: 25605720
Biochemistry. 2001 Jul 10;40(27):8065-72
pubmed: 11434775
Thromb Haemost. 2003 Apr;89(4):687-95
pubmed: 12669124
Expert Opin Ther Targets. 2017 Nov;21(11):1017-1026
pubmed: 28960088
J Membr Biol. 2000 Aug 1;176(3):223-36
pubmed: 10931974
Antimicrob Agents Chemother. 2004 May;48(5):1593-9
pubmed: 15105110
Exp Physiol. 2012 Feb;97(2):184-92
pubmed: 21908539
J Immunol. 2008 Jan 1;180(1):300-8
pubmed: 18097031
Biochim Biophys Acta. 2006 Aug;1761(8):812-26
pubmed: 16928468
Physiol Rev. 2016 Apr;96(2):605-45
pubmed: 26936867
Cell. 2017 Dec 14;171(7):1638-1648.e7
pubmed: 29224781
Nature. 2010 Dec 9;468(7325):834-8
pubmed: 21107324
Science. 2013 Jul 26;341(6144):403-6
pubmed: 23845944
Trends Cell Biol. 2015 Nov;25(11):639-650
pubmed: 26437594
Biochem Biophys Res Commun. 2007 Mar 30;355(1):169-73
pubmed: 17286963
Med Microbiol Immunol. 2012 Nov;201(4):419-26
pubmed: 22972233
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9182-7
pubmed: 15958533
Biochemistry. 2015 Sep 29;54(38):5791-801
pubmed: 26348730
Langmuir. 2008 Aug 19;24(16):9148-53
pubmed: 18605705
EMBO J. 2005 Feb 23;24(4):742-52
pubmed: 15692570
Front Mol Biosci. 2015 Oct 28;2:60
pubmed: 26579528
Sci Rep. 2016 May 06;6:25550
pubmed: 27151651
Elife. 2015 Jun 09;4:e06901
pubmed: 26057829
Hum Mol Genet. 2002 Oct 1;11(21):2615-24
pubmed: 12354787
J Cell Biol. 2004 Mar 1;164(5):769-79
pubmed: 14993236
J Biol Chem. 2004 Jun 11;279(24):25143-8
pubmed: 15066987
J Biol Chem. 2012 Jul 6;287(28):23678-89
pubmed: 22613720
Crit Rev Biochem Mol Biol. 2009 Sep-Oct;44(5):264-77
pubmed: 19780638
Blood. 2011 Apr 21;117(16):4399-400
pubmed: 21511967
Biophys J. 2005 Mar;88(3):1845-58
pubmed: 15596502
Eur J Cell Biol. 2011 Jun-Jul;90(6-7):527-35
pubmed: 21194787
Immunol Cell Biol. 2015 Jan;93(1):77-85
pubmed: 25155463
Nat Rev Cancer. 2008 Dec;8(12):929-41
pubmed: 19005493
Nat Commun. 2015 Feb 05;6:6245
pubmed: 25651887
Cell Cycle. 2016 Nov 16;15(22):2995-2996
pubmed: 27463373
Blood. 1998 Aug 1;92(3):946-51
pubmed: 9680363
Comb Chem High Throughput Screen. 2005 Mar;8(2):161-71
pubmed: 15777180

Auteurs

Florian Bleibaum (F)

Department of Dermatology, University of Kiel, Kiel, Germany.

Anselm Sommer (A)

Department of Dermatology, University of Kiel, Kiel, Germany.

Martin Veit (M)

Department of Dermatology, University of Kiel, Kiel, Germany.

Björn Rabe (B)

Institute of Biochemistry, University of Kiel, Olshausenstraße 40, Kiel, Germany.

Jörg Andrä (J)

Hamburg University of Applied Science, Ulmenliet 20, Hamburg, Germany.

Karl Kunzelmann (K)

Physiological Institute, University of Regensburg, Universitätsstraße 31, Regensburg, Germany.

Christian Nehls (C)

Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.

Wilmar Correa (W)

Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.

Thomas Gutsmann (T)

Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.

Joachim Grötzinger (J)

Institute of Biochemistry, University of Kiel, Olshausenstraße 40, Kiel, Germany.

Sucharit Bhakdi (S)

Department of Dermatology, University of Kiel, Kiel, Germany.

Karina Reiss (K)

Department of Dermatology, University of Kiel, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH